A mid-term review of the Research, Innovation and Enterprise 2020 (RIE 2020) plan resulted in Singapore putting in more funds for the research and development (R&D) efforts in three key areas, namely digital technologies, cell therapy manufacturing and food security.

According to a press release by National Research Foundation (NRF) on Wednesday (27 March), these additional investments will boost the “good progress” of the S$19 billion initiative which was launched in early-2016.

Ever since the RIEC embarked on the journey in 2006 to enrich the nation’s science and technology capabilities and values; progress has been made in terms of international recognition and significant breakthroughs by local scientists, as well as foreign companies like Dyson with their advanced product development facilities.

RIEC’s chairman, Prime Minister Lee Hsien Loong spoke at a press conference after a RIEC meeting about the significance of research, innovation and enterprise to Singapore’s development, especially in practical and useful products including autonomous vehicles.

“We must and we will continue to invest in science, technology and innovation in a balanced, sustained and sustainable manner. (This is) in order to keep Singapore competitive and relevant globally, and seed exciting new opportunities for our future economy,” Mr Lee said.

In regards to the mid-term review of the RIE2020, Mr Lee affirmed that Singapore is on track with the digital revolution but they are also sharpening focus and fine-tuning adjustments to their plans.

Earlier this month, Finance Minister Heng Swee Keat announced that the Government will invest an additional S$500 million to strengthen digital technologies and automation expertise; out of which, S$200 million will be invested in the nation’s supercomputing capability and network speed and ability.

Meanwhile, about S$41 million will be given to the National Robotics Programme to deploy more robotics technology while the rest of the funds would be used to expand existing programmes like Al Singapore and foster new capabilities in digital trust, the social science of digital technologies, and computational law.

Singapore will also be ploughing in S$80 million to develop a commercially scalable platform and improved technology to assess the quality of cells manufactured in the field of cell therapy, whereby intact living cells injected into patients help them to fight cancer or restore tissue or organ function.

“When you look at the future, it’s beyond what we currently manufacture today. Small molecules, biologics and cell therapy will be part of the future and we want to anchor those investments here in Singapore,” said Dr Benjamin Seet, executive director at the Agency for Science, Technology and Research’s (A*STAR) biomedical research council.

Besides that, some S$144 million from the RIE2020 plan will also be allocated for R&D work in sustainable urban food production, future food, as well as food safety science and innovation to meet the newly announced target of producing 30 per cent of the nation’s nutritional needs by 2030. Two Centres of Innovation focusing on aquaculture and energy are due to be opened in Temasek Polytechnic and the Nanyang Technological University by June and April, respectively.

Mr Lee also brought up the issue of the Government to achieve more progress in RIE investments from partnerships between the public and private sector. Currently, Singapore spends about 1 per cent of its gross domestic product on RIE efforts, while the private sector spends between 1.2 and 1.4 per cent, with an increase due to economic growth.

NRF chief executive Low Teck Seng said that there is still a need for more companies to incorporate R&D into their operations. He also highlighted the importance of continuous stock-take in science and technology as part of their ambition to grow the nation’s economy and build solutions to address national challenges.

Prof Low elaborated on NRF’s role in this area, stating, “The industry is not spending rapidly enough so we will need to keep pushing our tech consortia idea and others to see to get them more involved. In terms of tech deployment and diffusion, can we be more effective? I think we can.”

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments
You May Also Like

惊见名字日期不符 妻揭丈夫医药报告错误百出

在丈夫离世一个月后,妻子才发现丈夫的医疗报告上错误百出,病例和入院日期都写错,对院方的疏忽表示非常不满。樟宜综合医院获悉有关事件后,立刻修正错误文件,并且为此疏忽失误道歉。 丈夫潘坤顺为一名长期糖尿病患者,于今年6月15日在樟宜综合医院,因缺血性心脏病(ischemic heartdisease)离世,享年49岁。 他49岁的妻子,潘太太在经过一个月的丧期后,开始和家属亲人整理丈夫身前物件,发现院方发出的丈夫出院报告上写着别人的名字,才惊觉院方给错报告。 她的友人之后也帮忙检查有关保险食物,发现报告上也写着别人的姓名和年龄,方知一直以来她领着的出院报告都是别人的。 两份报告的个人资料都有问题,令她感到震惊和措手不及,立刻查看其它由院方提供的文件,随后在一份院方提供给保险公司额表格上发现丈夫的糖尿病例有误,将原本的19年写成30年。 她也发现到在医疗报告中,院方将丈夫住院病历日期写错,指其丈夫于7月7日被转入重护病房,但是丈夫已经在6月15日过世了。 种种的错误,令潘太太感到非常不满,表示这犹如在病患家属的伤口上撒盐。“我拿着别人的报告,是否也有人拿到我先生的报告呢?” 她指出,虽然院方表示没人领到其丈夫的报告,但是她过往失误已经令她感到不安,希望院方能够更加小心谨慎。 院方道歉补发正确报告 针对此事,樟宜综合医院服务营运总监吴敏龙指出,院方在获悉有关事件后,已经补发正确的医疗报告给潘太太,并且取回错误的文件。 他指出,院方对此次的失误事件以及所带来的影响感到抱歉,并且会认真看待此事,加强认证程序。“我们会让医院员工和接受者双方进行认证,避免类似事件重演。”…

丹绒巴葛安检站查获四把仿真枪 已交由警方侦办

丹绒巴葛安检站发现可疑货柜箱,并查获四把仿真枪。 移民与关卡局昨日(9日)在脸书上发表文告,当局于上周日(6日)对一个货柜箱进行扫描时,发现该货柜箱非常可疑。 据文告指出,该货柜箱申报为玩具和家用品,但因事有蹊跷,执法人员到进口商的场地进行拆柜,结果发现四把仿真枪和配件。 目前案件已转交警方侦办。 移民与关卡局重申,边境防卫我国安全的第一防线,类似的隐藏方式将可能被恐怖分子用于走私武器和爆炸物,并可能对新加坡展开袭击。 当局会继续在关卡进行安检,避免任何人企图偷渡或是走私毒品、武器、爆炸物或其他违禁品。

Speeding car flips at junction in Clementi, crashes into several vehicles

A speeding car flips and crashes into several vehicles at the junction…

SIA says it receives overwhelming “strong support” for its training center tours

It was reported earlier that Singapore Airlines (SIA) had incurred its first…